Notably, the inhibitory effect of Y-27632 on BPH tissue was more significant when compared with normal tissue (Fig. 1E), indicating the potentiating effect of RhoA-ROCK on prostatic tension. Here, RHOA is linked to benign prostatic hyperplasia.